These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 11044419)

  • 1. Evaluation of Marine Brown Algae and Sponges from Brazil as Anticoagulant and Antiplatelet Products.
    Moura LA; Ortiz-Ramirez F; Cavalcanti DN; Ribeiro SM; Muricy G; Teixeira VL; Fuly AL
    Mar Drugs; 2011; 9(8):1346-1358. PubMed ID: 21892349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating Anticoagulant and Antiplatelet Dual Functional Groups into Thermosetting Polymer Chain for Enhancing Antithrombogenicity.
    Wang W; Liu S; Zhang S; Zhang J; Tang Y; Zhang W
    Adv Healthc Mater; 2023 Oct; 12(26):e2300680. PubMed ID: 37515824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Infestin-4 Mutants with Increased Selectivity against Factor XIIa.
    Kolyadko VN; Lushchekina SV; Vuimo TA; Surov SS; Ovsepyan RA; Korneeva VA; Vorobiev II; Orlova NA; Minakhin L; Kuznedelov K; Severinov KV; Ataullakhanov FI; Panteleev MA
    PLoS One; 2015; 10(12):e0144940. PubMed ID: 26670620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation by factor Xa inhibitors.
    Orfeo T; Butenas S; Brummel-Ziedins KE; Gissel M; Mann KG
    J Thromb Haemost; 2010 Aug; 8(8):1745-53. PubMed ID: 20492473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow.
    Okorie UM; Denney WS; Chatterjee MS; Neeves KB; Diamond SL
    Blood; 2008 Apr; 111(7):3507-13. PubMed ID: 18203955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix protein microarrays for spatially and compositionally controlled microspot thrombosis under laminar flow.
    Okorie UM; Diamond SL
    Biophys J; 2006 Nov; 91(9):3474-81. PubMed ID: 16905604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of a HEMOCHRON JR. HEMONOX point of care test in monitoring the anticoagulant effects of enoxaparin during interventional coronary procedures.
    El Rouby S; Cohen M; Gonzales A; Hoppensteadt D; Lee T; Zucker ML; Khalid K; Laduca FM; Fareed J
    J Thromb Thrombolysis; 2006 Apr; 21(2):137-45. PubMed ID: 16622609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring the new antithrombotic drugs.
    Walenga JM; Hoppensteadt DA
    Semin Thromb Hemost; 2004 Dec; 30(6):683-95. PubMed ID: 15630675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the inhibition of both clot-associated thrombin and factor Xa more clinically relevant than either one alone?
    Meddahi S; Samama MM
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):207-14. PubMed ID: 19657318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel, bedside, tissue factor-dependent clotting assay permits improved assessment of combination antithrombotic and antiplatelet therapy.
    Holmes MB; Schneider DJ; Hayes MG; Sobel BE; Mann KG
    Circulation; 2000 Oct; 102(17):2051-7. PubMed ID: 11044419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT
    Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the antithrombotic effect of PEG-hirudin and heparin in a human ex vivo model of arterial thrombosis.
    Bossavy JP; Sakariassen KS; Rübsamen K; Thalamas C; Boneu B; Cadroy Y
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1348-53. PubMed ID: 10323789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future alternatives to heparin: low-molecular-weight heparin and hirudin.
    Donayre CE; Ouriel K; Rhee RY; Shortell CK
    J Vasc Surg; 1992 Apr; 15(4):675-82. PubMed ID: 1313932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory assays for the evaluation of recombinant hirudin.
    Walenga JM; Hoppensteadt D; Koza M; Wallock M; Pifarre R; Fareed J
    Haemostasis; 1991; 21 Suppl 1():49-63. PubMed ID: 1894197
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.